|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.19 USD | -0.21% |
|
-0.81% | +18.30% |
| Market Cap | 3.55B 3.08B 2.87B 2.63B 4.97B 338B 5.05B 33.82B 13.27B 168B 13.32B 13.02B 565B | P/E 2026 * |
-7.67x | P/E 2027 * | -8.36x |
|---|---|---|---|---|---|
| Enterprise Value | 2.92B 2.54B 2.37B 2.17B 4.1B 279B 4.17B 27.89B 10.95B 139B 10.98B 10.74B 466B | EV / Sales 2026 * |
34.4x | EV / Sales 2027 * | 35.3x |
| Free-Float |
70.85% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcus Biosciences, Inc.
| 1 day | -0.21% | ||
| 1 week | -0.81% | ||
| 1 month | -8.56% | ||
| 3 months | +10.55% | ||
| 6 months | +33.98% | ||
| Current year | +18.30% |
| 1 week | 26.19 | 29.63 | |
| 1 month | 25.68 | 31.23 | |
| Current year | 18.52 | 31.74 | |
| 1 year | 8.88 | 31.74 | |
| 3 years | 6.5 | 31.74 | |
| 5 years | 6.5 | 49.1 | |
| 10 years | 6.3 | 49.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Juan Jaen
PSD | President | 68 | 01/05/2015 |
Terry Rosen
CEO | Chief Executive Officer | 67 | 01/05/2015 |
Robert Goeltz
DFI | Director of Finance/CFO | 53 | 01/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Terry Rosen
CHM | Chairman | 67 | 01/12/2017 |
Kathryn Falberg
BRD | Director/Board Member | 65 | 18/09/2017 |
Yasunori Kaneko
BRD | Director/Board Member | 72 | 01/05/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/7/26 | Sell | Founder | -20,067 | 0.0160% | ||
| 11/6/26 | Free | Director | 22,600 | 0.0180% | ||
| 23/1/26 | Free | Chief Financial Officer | 157,000 | 0.1269% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.21% | -0.81% | +208.76% | +41.66% | 3.55B | ||
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | ||
| -2.41% | -0.90% | +403.17% | +614.40% | 39.87B | ||
| -1.16% | +12.96% | +26.45% | +5.03% | 38.68B | ||
| -1.88% | -3.03% | +4.94% | +47.52% | 35.13B | ||
| -1.74% | +5.12% | +9.58% | +46.02% | 29.79B | ||
| -2.85% | -3.92% | - | - | 16.08B | ||
| -0.21% | -4.04% | +35.09% | +127.95% | 16.11B | ||
| -0.64% | +2.65% | +1.25% | +8.92% | 13.61B | ||
| -1.19% | -1.32% | -3.32% | -34.94% | 12.62B | ||
| Average | -1.37% | +0.87% | +76.02% | +96.43% | 25.4B | |
| Weighted average by Cap. | -1.58% | +1.99% | +78.83% | +126.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 85.06M 73.94M 68.83M 63.19M 119M 8.12B 121M 811M 318M 4.04B 319M 312M 13.56B | 93.06M 80.89M 75.3M 69.13M 131M 8.88B 133M 888M 348M 4.42B 349M 342M 14.83B |
| Net income | -456M -397M -369M -339M -640M -43.57B -650M -4.35B -1.71B -21.69B -1.71B -1.68B -72.73B | -431M -374M -348M -320M -604M -41.1B -613M -4.11B -1.61B -20.46B -1.62B -1.58B -68.61B |
| Net Debt | -621M -540M -503M -462M -872M -59.31B -885M -5.93B -2.33B -29.53B -2.33B -2.28B -99.01B | -259M -225M -210M -193M -364M -24.76B -369M -2.47B -971M -12.33B -974M -953M -41.33B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | US$28.19 | -0.21% | 1,271,569 |
| 30/07/26 | US$28.25 | +6.81% | 813,637 |
| 29/07/26 | US$26.45 | -2.22% | 856,162 |
| 28/07/26 | US$27.05 | -2.84% | 1,580,324 |
| 27/07/26 | US$27.84 | -2.04% | 1,268,818 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RCUS Stock
Select your edition
All financial news and data tailored to specific country editions

















